CLINICAL ROLE -
FDA Grants Approval of myBETAapp, BETACONNECT Navigator for Relapsing-Remitting MS
The software helps track Interferon beta-1b injections among MS patients.
Read More
Affordable Care Act Plans Being Canceled by Patients
Many individuals have canceled ACA plans due to affordability issues.
CMS Seeks Public Input for Affordable Care Act
The Centers for Medicare & Medicaid Services seeking help to improve the future of the insurance marketplaces.
Altering Sequence of Cannabinoids, Chemotherapy Administration Improves Anticancer Effects
Sequence of drug administration is crucial to the success of combination treatments for cancer using cannabinoids.
CDC Greenlights Virus Removal Technique for HIV-Positive Men to Father Children
Medications that suppress viral loads aid HIV-infected men who want children.
Jardiance to Enter Clinical Testing for Chronic Kidney Disease
Results from the EMPA-REG OUTCOME trial suggests empagliflozin (Jardiance) has potential in the treatment of chronic kidney disease.
Experimental Cancer Drug May Also Treat Heart Failure
Investigational cancer drug blocks inflammation and fibrosis in heart cells.
Diplomat Now Dispensing Sarilumab to Treat Rheumatoid Arthritis
The drug offers a new therapeutic option to help manage RA.
Sofosbuvir Reduces Need for Liver Transplants in Patients with Hepatitis C
HCV drug greatly reduced the rates of liver transplants and mortality in patients with advanced stages of cirrhosis.
Hybrid Closed-Loop System Favorable for Type 1 Diabetes
Closed-loop systems help diabetes patients achieve blood glucose control, according to a presentation at the American Diabetes Association’s 77th Scientific Sessions.
Transition Programs Beneficial for Youth with Diabetes Moving to Adult Care
Transition care may improve diabetes outcomes, according to a study presented at the American Diabetes Association’s 77th Scientific Sessions.
EMA Releases Guide on Biosimilars in the EU
The guide seeks to provide health care professionals with reference information on the science and regulation underpinning biosimilar use.
Trending News Today: Senate Continues Push to Pass AHCA
Top news of the day from across the healthcare landscape.
Antibody-Based Biosensor Can Monitor Drug Levels
New biosensor can detect methotrexate, theophylline, and quinine in the blood.
Trending News Today: Supreme Court Ruling Paves the Way for Biosimilar Growth
Top news of the day from across the health care landscape.
Continuous Glucose Monitoring Beneficial for Patients with Diabetes
American Diabetes Association’s 77th Scientific Sessions highlight benefits of glucose monitoring.
NCPA Highlights Role of PBMs in Rising Prescription Drug Prices to U.S. Senate HELP Committee
5 Smoking Cessation Studies Every Pharmacist Should Know
Over the years, a number of landmark clinical studies on smoking cessation pharmacotherapy have been published, shaping how we treat people today. Here are 5 of those that every pharmacist should know:
Pharmacists: Attend a Non-Pharmacy Conference
Taking advantage of all the value that nonpharmacy organizations have to offer.
Metformin Observed to Reduce Heart Disease Risk in Type 1 Diabetes
REMOVAL trial results presented at the American Diabetes Association’s 77th Scientific Sessions.
Personalized Dosing in Firstline Advanced Lung Cancer Would Save US Millions
The FDA recommends a 200-mg dose of pembrolizumab every 3 weeks, but researchers disagree.
State Biosimilar Bill Signed into Law
Another state passes legislation to increase uptake of biosimilars.
Physician Satisfaction May Influence Oncology Prescribing
Taking steps to improve customer satisfaction may increase oncology revenue for manufacturers.
Guardians of the Galaxy Star Calls Attention to HIV Awareness in Sia Music Video
HIV/AIDS is the number 1 killer among women of reproductive age.
Healthy Obesity Still Leads to Cardiovascular Events
Patients with metabolically healthy obesity have a 50% increased risk of coronary heart disease.
HDAC Inhibitors May Have Potential to Treat Psoriasis
Agents fight cancer by temporarily loosening DNA, increasing the expression of tumor suppressors, and making the tumor more vulnerable.
FDA Approves Oral Powder for Pediatric HIV Treatment
Powder formulation of HIV drug receives FDA approval.
Pharmacy Week in Review: June 9, 2017
A look at the top stories in pharmacy last week.
Watch
Oral Pediatric HIV Treatment Gets FDA Approval
Ritonavir is indicated in combination with other antiretroviral agents for the treatment of pediatric patients with HIV-1.
Illicit Drug Use Significantly Underreported
Survey methods may lead to varying responses to questions related to drug use.
